2021
DOI: 10.1055/s-0040-1722337
|View full text |Cite
|
Sign up to set email alerts
|

Nasal Intermittent Positive Pressure Ventilation versus Continuous Positive Airway Pressure and Apnea of Prematurity: A Systematic Review and Meta-Analysis

Abstract: Objective The study aimed to systematically review and analyze the impact of nasal intermittent positive pressure ventilation (NIPPV) versus continuous positive airway pressure (CPAP) on apnea of prematurity (AOP) in preterm neonates. Study Design In this systematic review and meta-analysis, experimental studies enrolling preterm infants comparing NIPPV (synchronized, nonsynchronized, and bi-level) and CPAP (all types) were searched in multiple databases and screened for the assessment of AOP. Prim… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
4
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
2

Relationship

1
6

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 32 publications
(48 reference statements)
0
4
0
Order By: Relevance
“…26 An updated systematic review identified 6 additional studies and found no difference in frequency of apnea with NIPPV vs. CPAP upon meta-analysing the available data. 27 However, the pooled odds of developing any apneas were reduced.…”
Section: Additional Limitations In Current Knowledge On Nippvmentioning
confidence: 99%
See 2 more Smart Citations
“…26 An updated systematic review identified 6 additional studies and found no difference in frequency of apnea with NIPPV vs. CPAP upon meta-analysing the available data. 27 However, the pooled odds of developing any apneas were reduced.…”
Section: Additional Limitations In Current Knowledge On Nippvmentioning
confidence: 99%
“…26 An updated systematic review identified six additional studies and found no difference in frequency of apnea with NIPPV versus CPAP upon meta-analysis of the available data. 27 However, the pooled odds of developing any apneas were reduced. No firm conclusions could be drawn due to the significant heterogeneity in study designs and outcomes, as well as the fact that apnea was a secondary outcome in most studies and selective reporting could not be ruled out.…”
Section: Additional Limitations In Current Knowledge On Nasal Intermi...mentioning
confidence: 99%
See 1 more Smart Citation
“…85 AOP is nearly universal in infants born at <29 weeks GA and often resolves by 37 weeks PMA, although it may persist in some infants, particularly those born at <28 weeks GA. 86 Management includes methylxanthines and respiratory support with supplemental oxygen, nasal continuous positive airway pressure (nCPAP), NIPPV, or invasive ventilation. [86][87][88][89] Other general measures include maintaining thermal stability, treatment of anemia and metabolic abnormalities, and ruling-out other causes (e.g., sepsis, necrotizing enterocolitis, seizures, central nervous system pathology).…”
Section: Central Sleep Apnea In Infantsmentioning
confidence: 99%
“… Ребенку с апноэ недоношенных при неэффективности медикаментозной терапии (сохранение частоты и/или тяжести эпизодов апноэ на фоне проведения терапии кофеином) с лечебной целью рекомендуется проведение неинвазивной респираторной терапии [СРАР, NCPAP, NIPPV (nasal intermittent positive pressure ventilation)] [1,23,25,58,96,[107][108][109][110].…”
Section: респи раторная терапияunclassified